UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Analysis of the effect of urine on the in vitro activity of gepotidacin and levofloxacin against Escherichia coli, Staphylococcus epidermidis, and Staphylococcus saprophyticus

Diagnostic microbiology and infectious disease, 2023-07, Vol.106 (3), p.115946-115946, Article 115946

2023

Volltextzugriff (PDF)

Correlation of Vitek 2 and Agar dilution for levofloxacin susceptibility testing and clinical outcomes of Enterobacterales bacteremia with 2019 CLSI breakpoints

Diagnostic microbiology and infectious disease, 2022-12, Vol.104 (4), p.115799-115799, Article 115799

2022

Volltextzugriff (PDF)

A randomized controlled clinical trial of levofloxacin 750 mg versus 500 mg intravenous infusion in the treatment of community-acquired pneumonia

Diagnostic microbiology and infectious disease, 2014-10, Vol.80 (2), p.141-147

2014

Volltextzugriff (PDF)

Bioequivalence and in vitro antimicrobial activity between generic and brand-name levofloxacin

Diagnostic microbiology and infectious disease, 2016-07, Vol.85 (3), p.347-351

2016

Volltextzugriff (PDF)

Delafloxacin against Helicobacter pylori, a potential option for improving eradication success?

Diagnostic microbiology and infectious disease, 2020-04, Vol.96 (4), p.114980-114980, Article 114980

2020

Volltextzugriff (PDF)

Emergence of multidrug-resistant clones in levofloxacin-nonsusceptible Streptococcus pneumoniae isolates in Korea

Diagnostic microbiology and infectious disease, 2018-07, Vol.91 (3), p.287-290

2018

Volltextzugriff (PDF)

Primary Helicobacter pylori resistance to antimicrobials in the Brussels area in 2021

Diagnostic microbiology and infectious disease, 2023-02, Vol.105 (2), p.115855-115855, Article 115855

2023

Volltextzugriff (PDF)

Probability of target attainment of oral antimicrobials for Escherichia coli and Klebsiella pneumoniae based on Monte Carlo simulations

Diagnostic microbiology and infectious disease, 2022-05, Vol.103 (1), p.115662-115662, Article 115662

2022

Volltextzugriff (PDF)

Levofloxacin susceptibility testing against Helicobacter pylori : evaluation of a modified disk diffusion method compared to E test

Diagnostic microbiology and infectious disease, 2016, Vol.84 (1), p.55-56

2016

Volltextzugriff (PDF)

Characterization of variables that may influence ozenoxacin in susceptibility testing, including MIC and MBC values

Diagnostic microbiology and infectious disease, 2014-03, Vol.78 (3), p.263-267

2014

Volltextzugriff (PDF)

Laboratory evaluation of the Anyplex™ II MTB/MDR and MTB/XDR tests based on multiplex real-time PCR and melting-temperature analysis to identify Mycobacterium tuberculosis and drug resistance

Diagnostic microbiology and infectious disease, 2017-12, Vol.89 (4), p.276-281

2017

Volltextzugriff (PDF)

Performance of the MTBDRsl Line probe assay for rapid detection of resistance to second-line anti-tuberculosis drugs and ethambutol in China

Diagnostic microbiology and infectious disease, 2017-10, Vol.89 (2), p.112-117

2017

Volltextzugriff (PDF)

High prevalence of multiresistance in levofloxacin-nonsusceptible Streptococcus pneumoniae isolates in Korea

Diagnostic microbiology and infectious disease, 2013-06, Vol.76 (2), p.227-231

2013

Volltextzugriff (PDF)

Helicobacter pylori susceptibility to fosfomycin, rifampin, and 5 usual antibiotics for H. pylori eradication

Diagnostic microbiology and infectious disease, 2014-07, Vol.79 (3), p.358-361

2014

Volltextzugriff (PDF)

Integrated results of 2 phase 3 studies comparing tigecycline and levofloxacin in community-acquired pneumonia

Diagnostic microbiology and infectious disease, 2008-07, Vol.61 (3), p.329-338

2008

Volltextzugriff (PDF)

Safety and efficacy of intravenous tigecycline in treatment of community-acquired pneumonia: results from a double-blind randomized phase 3 comparison study with levofloxacin

Diagnostic microbiology and infectious disease, 2009-01, Vol.63 (1), p.52-61

2009

Volltextzugriff (PDF)

Biofilm formation by Streptococcus pneumoniae strains and effects of human serum albumin, ibuprofen, N -acetyl- l -cysteine, amoxicillin, erythromycin, and levofloxacin

Diagnostic microbiology and infectious disease, 2010-08, Vol.67 (4), p.311-318

2010

Volltextzugriff (PDF)

Lactational mastitis caused by Streptococcus lactarius

Diagnostic microbiology and infectious disease, 2016-08, Vol.85 (4), p.490-492

2016

Volltextzugriff (PDF)

Effect of oxygen limitation on the in vitro activity of levofloxacin and other antibiotics administered by the aerosol route against Pseudomonas aeruginosa from cystic fibrosis patients

Diagnostic microbiology and infectious disease, 2010-02, Vol.66 (2), p.181-186

2010

Volltextzugriff (PDF)

Treatment of KPC-2 Enterobacter cloacae empyema with cefepime and levofloxacin

Diagnostic microbiology and infectious disease, 2014-02, Vol.78 (2), p.199-200

2014

Volltextzugriff (PDF)

Differences in distribution and antimicrobial susceptibility of anaerobes isolated from complicated intra-abdominal infections versus diabetic foot infections

Diagnostic microbiology and infectious disease, 2013-08, Vol.76 (4), p.546-548

2013

Volltextzugriff (PDF)

Antimicrobial susceptibility of Streptococcus pyogenes in Central, Eastern, and Baltic European Countries, 2005 to 2006: the cefditoren surveillance program

Diagnostic microbiology and infectious disease, 2009-05, Vol.64 (1), p.52-56

2009

Volltextzugriff (PDF)

Sepsis caused by Elizabethkingia miricola successfully treated with tigecycline and levofloxacin

Diagnostic microbiology and infectious disease, 2008-12, Vol.62 (4), p.430-432

2008

Volltextzugriff (PDF)

Pathotype and susceptibility profile of a community-acquired methicillin-resistant Staphylococcus aureus strain responsible for a case of severe pneumonia

Diagnostic microbiology and infectious disease, 2009-01, Vol.63 (1), p.100-104

2009

Volltextzugriff (PDF)

Activity of JNJ-Q2 against Staphylococcus aureus isolated from patients with acute bacterial skin and skin-structure infection obtained during a Phase 2 clinical trial

Diagnostic microbiology and infectious disease, 2012-09, Vol.74 (1), p.73-74

2012

Volltextzugriff (PDF)

1 – 25 von 82

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieDiagnostic Microbiology And Infectious Disease

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(82)
Mit Volltextzugriff
(82)

Publikationsform

Artikel
(82)

Sprache

Englisch
(82)

Erscheinungsjahr

n.n

Kollektion

Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(82)
Ingenta
(82)
Elsevier ScienceDirect Journals Complete
(82)
MEDLINE
(79)
IngentaConnect Journals
(31)

Zeitschrift / Serie

Diagn Microbiol Infect Dis
(1)

Menü

Weitere Dienste

Einstellungen

Analysis of the effect of urine on the in vitro activity of gepotidacin and levofloxacin against Escherichia coli, Staphylococcus epidermidis, and Staphylococcus saprophyticus

Correlation of Vitek 2 and Agar dilution for levofloxacin susceptibility testing and clinical outcomes of Enterobacterales bacteremia with 2019 CLSI breakpoints

A randomized controlled clinical trial of levofloxacin 750 mg versus 500 mg intravenous infusion in the treatment of community-acquired pneumonia

Bioequivalence and in vitro antimicrobial activity between generic and brand-name levofloxacin

Delafloxacin against Helicobacter pylori, a potential option for improving eradication success?

Emergence of multidrug-resistant clones in levofloxacin-nonsusceptible Streptococcus pneumoniae isolates in Korea

Primary Helicobacter pylori resistance to antimicrobials in the Brussels area in 2021

Probability of target attainment of oral antimicrobials for Escherichia coli and Klebsiella pneumoniae based on Monte Carlo simulations

Levofloxacin susceptibility testing against Helicobacter pylori : evaluation of a modified disk diffusion method compared to E test

Characterization of variables that may influence ozenoxacin in susceptibility testing, including MIC and MBC values

Laboratory evaluation of the Anyplex™ II MTB/MDR and MTB/XDR tests based on multiplex real-time PCR and melting-temperature analysis to identify Mycobacterium tuberculosis and drug resistance

Performance of the MTBDRsl Line probe assay for rapid detection of resistance to second-line anti-tuberculosis drugs and ethambutol in China

High prevalence of multiresistance in levofloxacin-nonsusceptible Streptococcus pneumoniae isolates in Korea

Helicobacter pylori susceptibility to fosfomycin, rifampin, and 5 usual antibiotics for H. pylori eradication

Integrated results of 2 phase 3 studies comparing tigecycline and levofloxacin in community-acquired pneumonia

Safety and efficacy of intravenous tigecycline in treatment of community-acquired pneumonia: results from a double-blind randomized phase 3 comparison study with levofloxacin

Biofilm formation by Streptococcus pneumoniae strains and effects of human serum albumin, ibuprofen, N -acetyl- l -cysteine, amoxicillin, erythromycin, and levofloxacin

Lactational mastitis caused by Streptococcus lactarius

Effect of oxygen limitation on the in vitro activity of levofloxacin and other antibiotics administered by the aerosol route against Pseudomonas aeruginosa from cystic fibrosis patients

Treatment of KPC-2 Enterobacter cloacae empyema with cefepime and levofloxacin

Differences in distribution and antimicrobial susceptibility of anaerobes isolated from complicated intra-abdominal infections versus diabetic foot infections

Antimicrobial susceptibility of Streptococcus pyogenes in Central, Eastern, and Baltic European Countries, 2005 to 2006: the cefditoren surveillance program

Sepsis caused by Elizabethkingia miricola successfully treated with tigecycline and levofloxacin

Pathotype and susceptibility profile of a community-acquired methicillin-resistant Staphylococcus aureus strain responsible for a case of severe pneumonia

Activity of JNJ-Q2 against Staphylococcus aureus isolated from patients with acute bacterial skin and skin-structure infection obtained during a Phase 2 clinical trial

Aktive Filter

Suchergebnisse filtern